# Alexandria Real Estate Equities **Source:** https://geo.sig.ai/brands/alexandria-real-estate-equities **Vertical:** Real Estate & Property Tech **Subcategory:** Enterprise **Tier:** Leader **Website:** are.com **Last Updated:** 2026-04-14 ## Summary Pasadena life science campus REIT (NYSE: ARE) with 39.7M RSF at $25.7B market cap; largest company lease ever (466,598 RSF/16-year pharma at San Diego Campus Point) and $3.12B 2024 revenue competing with Healthpeak for biotech lab REIT. ## Company Overview Alexandria Real Estate Equities, Inc. is a Pasadena, California-based life science real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: ARE) as an S&P 500 REIT — operating as the preeminent owner, operator, and developer of collaborative life science, technology, and agtech Megacampus ecosystems in AAA innovation cluster locations including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland/DC, Research Triangle, and New York City. As of June 30, 2025, Alexandria has a $25.7 billion total market capitalization and manages 39.7 million rentable square feet (RSF) of operating properties and 4.4 million RSF of Class A/A+ properties under construction. In 2024, Alexandria reported $3.12 billion in revenue (+8.20%). The company executed its largest single lease in history — a 16-year agreement with a multinational pharmaceutical tenant for 466,598 RSF at the Campus Point Megacampus in San Diego (98.8% occupied). Executive Chairman and Founder: Joel Marcus; Co-CEOs: Stephen Richardson and Peter Moglia. Founded 1994. Alexandria's life science campus REIT model addresses the specialized real estate infrastructure requirements of biotech, pharmaceutical, and genomics companies that cannot operate in conventional Class A office buildings: wet lab research facilities require reinforced floor loading (for equipment), dedicated biosafety exhaust systems, chemical fume hoods, vivarium space for animal research, and electrical/data infrastructure at 5-10x the density of office buildouts — requirements that conventional commercial real estate developers build once for a specific tenant rather than designing for flexible multi-tenant research workflows. Alexandria's Megacampus model (purpose-built clustered lab buildings on owned campuses in proven biotech markets adjacent to research universities and hospitals) creates the vibrant scientific community that attracts and retains talent — with proximity to UCSF, Harvard Medical School, MIT, and leading teaching hospitals providing the academic collaboration network that drug discovery requires. In 2025, Alexandria competes in the life science real estate, biotech campus, and innovation district REIT market with Healthpeak Properties (NYSE: DOC, life science REIT, $2.4B revenue), BioMed Realty Trust (Blackstone private, life science, $7B+ assets), and Boston Properties (NYSE: BXP, mixed office/life science, $3.1B revenue) for biotech and pharmaceutical company lease commitments, campus expansion agreements, and build-to-suit development mandates in top-tier innovation markets. The 74% of rental revenue from Megacampuses creates concentration in high-demand nodes (Kendall Square Cambridge, Mission Bay San Francisco, Torrey Pines San Diego) where supply constraints and proximity to anchor research institutions create durable rent premium. The largest lease in Alexandria's history (466,598 RSF multinational pharma at Campus Point, 16-year term) demonstrates the demand from large pharmaceutical companies for purpose-built research campuses at scale. The 2025 strategy focuses on completing the 4.4M RSF development pipeline in its strongest markets, growing the AI-health tech tenant mix alongside traditional biotech, and managing the development pipeline conservatively given public life science market funding cycles. ## Frequently Asked Questions ### What does Alexandria Real Estate Equities do? Alexandria Real Estate Equities is an S&P 500 life science REIT that owns, operates, and develops collaborative Megacampus ecosystems specifically designed for life science, technology, and agtech companies. The company provides specialized laboratory and office space in premier innovation clusters near research universities and institutions. ### When was Alexandria Real Estate Equities founded? Alexandria was founded in 1994 by Joel Marcus, Jerry Sudarsky, and Alan Gold, starting as a garage startup with $19 million in Series A capital. The company became the first REIT to focus exclusively on life science real estate and completed its NYSE IPO in May 1997. ### Where is Alexandria Real Estate Equities based? Alexandria is headquartered in Pasadena, California, USA. The company operates collaborative Megacampus ecosystems in premier AAA life science innovation clusters including Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. ### Who leads Alexandria Real Estate Equities? Alexandria is led by Executive Chairman and Founder Joel S. Marcus, who founded the company in 1994 and served as CEO from 1997-2018. Co-CEOs Stephen A. Richardson and Peter M. Moglia jointly lead day-to-day operations and report to Marcus and the board of directors. ### What is Alexandria's revenue? Alexandria reported 2024 revenue of $3.12 billion, representing 8.20% growth compared to 2023's $2.89 billion. The company has a market capitalization of $25.7 billion as of June 30, 2025 and operates 39.7 million RSF of properties. ### What makes Alexandria different from competitors? Alexandria is the preeminent and longest-tenured life science REIT, pioneering the sector since 1994. The company differentiates through its focus on collaborative Megacampus ecosystems (74% of revenue), premier AAA cluster locations near research institutions, 54% LEED-certified portfolio, and integrated approach including venture capital through Alexandria Venture Investments. ### Who are Alexandria's main competitors? Alexandria's main competitors in life science real estate include BioMed Realty (Blackstone's life sciences arm with 14.9M SF), Healthpeak Properties (12.2M SF), Ventas (10M SF), and Longfellow. Alexandria is the largest with approximately 47 million square feet, significantly exceeding competitors. ### How many properties does Alexandria own? As of June 30, 2025, Alexandria has an asset base of 39.7 million rentable square feet (RSF) of operating properties and 4.4 million RSF of Class A/A+ properties undergoing construction in North America, representing one of the largest life science real estate portfolios globally. ### What is Alexandria's occupancy rate? Alexandria's operating occupancy has faced recent challenges, decreasing from 94.7% as of September 30, 2024 to 90.6% as of September 30, 2025 over four consecutive quarters, though the company continues to secure major new leases including its largest-ever 466,598 RSF agreement. ### What are Alexandria's recent developments? Recent developments include executing the largest life science lease in company history (466,598 RSF at Campus Point), completing $1.1B in strategic dispositions in Q4 2024, achieving 18% reduction in operational GHG emissions intensity (2022-2024), and opening Lilly Gateway Labs San Diego at One Alexandria Square Megacampus. ### What is Alexandria's sustainability commitment? Alexandria has achieved 18% reduction in operational GHG emissions intensity from 2022-2024, progressing toward its 30% reduction target by 2030. 54% of annual rental revenue comes from LEED-certified properties. The company has received GRESB Green Star designation for eight consecutive years and won the 2024 Nareit Sustainable Design Impact Award. ### How can I contact Alexandria Real Estate Equities? You can contact Alexandria through their website at www.are.com or their headquarters in Pasadena, California. The company serves leading life science, pharmaceutical, biotechnology, and agtech companies across its premier innovation cluster locations in North America. ## Tags b2b, enterprise, proptech, public, saas --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*